Health and Fitness Health and Fitness
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012
Tue, June 26, 2012
Mon, June 25, 2012
[ Mon, Jun 25th 2012 ] - Market Wire
Myths or Factsa" Campaign
Sun, June 24, 2012
Sat, June 23, 2012
Fri, June 22, 2012
Thu, June 21, 2012
Wed, June 20, 2012
Tue, June 19, 2012

Daxor Corporation Announces Filing of Form N-2 and Seven Trial Agreements for the Daxor BVA-100 Blood Volume Analyzer


Published on Friday, June 29th 2012 at 5:36 GMT by Market Wire   Print publication without navigation


June 29, 2012 08:30 ET

Daxor Corporation Announces Filing of Form N-2 and Seven Trial Agreements for the Daxor BVA-100 Blood Volume Analyzer

NEW YORK, NY--(Marketwire - Jun 29, 2012) - Daxor Corporation (NYSE MKT: [ DXR ]), a medical instrumentation and biotechnology company, has registered as an investment company. The Company filed a Form N-2 (Registration Statement Under the Investment Company Act of 1940) yesterday, June 28th.

Daxor has begun reporting as an investment company effective January 1, 2012. The Company filed a Form N-Q disclosing its schedule of portfolio holdings as of March 31, 2012.

The Company's next public report will be a Form N-CSR which will be for the six months ended June 30, 2012. This report will be filed with the SEC and sent to shareholders before the end of August 2012.

Since January 1, 2012, the Company has placed seven BVA-100 Blood Volume Analyzers on a trial basis in separate locations within the Continental United States. There are currently 65 Blood Volume Analyzers in service.

Daxor Corporation manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at [ www.Daxor.com ].



Publication Contributing Sources